Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Andreessen Horowitz
MedTech
AI drug designer Genesis nets $200M with eye on clinical testing
First spun out of Stanford in late 2019, Genesis' platform helps design small-molecule drugs and predicts how they interact with the body.
Conor Hale
Aug 21, 2023 10:45am
Women left out of VC club fight for their identity
Jun 7, 2023 7:00am
Investors eye less risky bets, shift away from platform biotechs
Jan 23, 2023 11:19am
New Beam-buoyed biotech takes flight, gravitating toward RNA
Sep 7, 2022 11:22am
Cartography gets on the map with $57M for immunotherapies
Jul 19, 2022 10:00am
Amgen dons BigHat to bring AI insights to next-gen antibodies
Jan 11, 2022 8:00am